WELL Health Technologies Corp. (WELL:CA) — TD Securities maintained its Buy rating with a C$8.50 price target. WELL Health reported record second-quarter revenue, strong growth in Canadian patient services and higher annual guidance, supported by acquisitions and organic expansion. Looking ahead, investors will be watching whether clinic growth improves earnings and free cash flow per share. Acquisition integration, staffing costs and balance-sheet discipline remain important as the healthcare platform expands.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.